Gut Liver.  2014 Jan;8(1):88-93.

Fiducial Placement for Stereotactic Body Radiation Therapy under Only Endoscopic Ultrasonography Guidance in Pancreatic and Hepatic Malignancy: Practical Feasibility and Safety

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. dwseoamc@amc.seoul.kr

Abstract

BACKGROUND/AIMS
Stereotactic body radiation therapy (SBRT) for gastrointestinal malignancies requires the placement of fiducials to guide treatment delivery. This study aimed to determine the safety and technical feasibility of endoscopic ultrasonography (EUS)-guided fiducial placement for SBRT.
METHODS
From November 2010 to August 2012, 32 consecutive patients who were scheduled to receive SBRT for pancreatic and hepatic malignancies were referred for EUS-guided fiducial placement. Primary outcome measurements included technical success, the fiducial migration rate, and procedural complications.
RESULTS
All 32 patients had successful fiducial placement under EUS guidance. The mean number of fiducials placed per patient was 2.94+/-0.24 (range, 2 to 3 seeds). Spontaneous fiducial migration was noted in one patient (3.1%). Of the 32 patients with fiducials placed, 29 patients (90.6%) successfully underwent SBRT. One patient (3.1%) developed mild pancreatitis, requiring a 2-day prolonged hospitalization after fiducial placement. Five patients (15.6%) underwent same-session, EUS-guided fine needle aspiration for histologic confirmation at the time of fiducial placement, without any procedure-related complication.
CONCLUSIONS
EUS-guided fiducial placement is a safe and technically feasible technique for preparing patients with both pancreatic and hepatic malignancies for SBRT. The fiducial markers facilitate safe and accurate targeting of the tumor during SBRT.

Keyword

Fiducial markers; Endosonography; Radiosurgery; Pancreatic neoplasms; Liver neoplasms

MeSH Terms

Aged
Aged, 80 and over
Endosonography/*methods
Equipment Design
Feasibility Studies
Female
*Fiducial Markers
Humans
Liver Neoplasms/*radiotherapy/ultrasonography
Male
Middle Aged
Needles
Pancreatic Neoplasms/*radiotherapy/ultrasonography
Radiosurgery/*methods
Treatment Outcome
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr